Palatin Technologies, Inc. (LON:0KF3)
London · Delayed Price · Currency is GBP · Price in USD 18.50
-0.28 (-1.49%)
May 8, 2026, 3:47 PM GMT
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of 24.06 million as of May 8, 2026. Its market cap has increased by 16.10% in one year.
Market Cap
24.06M
Enterprise Value
13.69M
Revenue
6.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.50
Market Cap Chart
Since January 29, 2018, Palatin Technologies's market cap has decreased from 124.07M to 24.06M, a decrease of -80.61%. That is a compound annual growth rate of -17.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 24.45M | -30.47% |
| Dec 11, 2025 | 35.16M | 61.85% |
| Dec 31, 2024 | 21.72M | -43.72% |
| Dec 29, 2023 | 38.60M | 99.29% |
| Dec 28, 2022 | 19.37M | -79.00% |
| Dec 30, 2021 | 92.25M | -28.03% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.41B |
| GSK plc | 74.85B |
| Haleon | 29.66B |
| Smith & Nephew | 9.90B |
| Poolbeg Pharma | 31.73M |
| Inspiration Healthcare Group | 27.62M |
| Sareum Holdings | 27.61M |
| ImmuPharma | 26.83M |